|
SCARB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.384000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.863400E-01 |
| Normal-vs-Stage2 |
8.925400E-01 |
| Normal-vs-Stage3 |
1.581210E-01 |
| Normal-vs-Stage4 |
1.007380E-01 |
| Stage1-vs-Stage2 |
8.517800E-01 |
| Stage1-vs-Stage3 |
2.226400E-02 |
| Stage1-vs-Stage4 |
1.430280E-02 |
| Stage2-vs-Stage3 |
2.760400E-01 |
| Stage2-vs-Stage4 |
1.917970E-01 |
| Stage3-vs-Stage4 |
7.190600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.432600E-01 |
| Normal-vs-AfricanAmerican |
9.709900E-02 |
| Normal-vs-Asian |
5.601200E-01 |
| Caucasian-vs-AfricanAmerican |
8.885700E-02 |
| Caucasian-vs-Asian |
5.744600E-01 |
| AfricanAmerican-vs-Asian |
1.883790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.475000E-01 |
| Normal-vs-Female |
8.828600E-01 |
| Male-vs-Female |
6.030800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.167200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.946800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.076400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.029000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.831800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.706600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.712600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.342800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.884600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.690400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.847800E-02 |
| Normal-vs-Grade 2 |
2.998400E-01 |
| Normal-vs-Grade 3 |
1.768820E-01 |
| Normal-vs-Grade 4 |
1.656410E-02 |
| Grade 1-vs-Grade 2 |
3.469400E-01 |
| Grade 1-vs-Grade 3 |
2.286000E-02 |
| Grade 1-vs-Grade 4 |
4.643500E-03 |
| Grade 2-vs-Grade 3 |
3.375500E-03 |
| Grade 2-vs-Grade 4 |
3.760200E-04 |
| Grade 3-vs-Grade 4 |
1.568760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.848400E-01 |
| Normal-vs-ccB subtype |
7.407000E-01 |
| ccA subtype-vs-ccB subtype |
1.244240E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.356600E-01 |
| Normal-vs-N1 |
9.612200E-01 |
| N0-vs-N1 |
8.418200E-01 |
|
|
